Health provision integration platform Healthify has now raised $28m in equity and grants after a series B round involving BlueCross BlueShield Venture Partners.

Honeywell Ventures was among the investors in drug manufacturing informatics company Bigfinite’s latest round, with the proceeds slated to grow the market for its platform.

Lilly Asia Ventures returned for a $100m series C round, after the corporate venturing unit previously also backed a series B round of undisclosed size last year.

Co-founded by Innovative Targeting Solutions, A2 Biotherapeutics has emerged from stealth with $57m in series A financing to develop cell therapies for cancer.

Guangzhou Kingmed has led a $31m series C round for genome sequencing company Yikon Genomics, which was spun out of Harvard University five years ago.

Bayer has led a $25m series B round for Medopad, which allows patients to capture healthcare data through smartphones and watches.

Sino Biopharmaceutical has co-led the series D round together with Loyal Valley Capital, while K. Wah Group also contributed.

Merck Global Health Innovation Fund and Bristol-Myers Squibb have provided the final tranche for PathAI’s $75m series B round, adding to an earlier commitment from LabCorp.

Sensely has collected funding from a consortium led by insurance firm Aflac to haul its lifetime total to $26.5m.

Genomics bioinformatics platform developer PierianDx has raised capital from investors including Inova Health Systems and RTI International to advance its business strategy.